Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Net Income towards Common Stockholders (2016 - 2025)

Standard Biotools (LAB) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with -$3.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 40.18% to -$3.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$103.4 million, a 111.31% decrease, with the full-year FY2024 number at -$184.9 million, down 147.67% from a year prior.
  • Net Income towards Common Stockholders was -$3.0 million for Q3 2025 at Standard Biotools, up from -$33.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $153.2 million in Q4 2022 to a low of -$76.3 million in Q1 2022.
  • A 5-year average of -$14.9 million and a median of -$18.8 million in 2021 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 1724.73% in 2022, then crashed 348.54% in 2024.
  • Standard Biotools' Net Income towards Common Stockholders stood at -$9.4 million in 2021, then surged by 1724.73% to $153.2 million in 2022, then plummeted by 91.05% to $13.7 million in 2023, then crashed by 348.54% to -$34.1 million in 2024, then skyrocketed by 91.19% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Net Income towards Common Stockholders are -$3.0 million (Q3 2025), -$33.5 million (Q2 2025), and -$32.8 million (Q1 2025).